Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economics

Even Healthcare reaches a $300 million valuation in a Khosla Ventures-led round as it plans to expand its hospital network in India.

Mark Wahlberg wants to take on the longevity-startup crowd with an affordable gym concept

Mark Wahlberg, who once sank money into a gym chain that got kicked off the NYSE, is now building his own, and he promises you’ll get a cold plunge, a blood panel and a protein muffin without needing a trust fund.

TechCrunch Disrupt 2026: Last day

Last day to join TechCrunch Disrupt 2026. Join 10,000+ tech leaders for a day of connections and insights. Save 75% on your pass now.

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

Colossal Biosciences announces new AI platform to help accelerate de-extinction efforts

Colossal announced a new AI platform to help accelerate its de-extinction efforts and Peter Diamandis has launched a new fund to back startups who use it.

TimeTeller puts our internal clocks at the center of personalized medicine

German startup TimeTeller has developed a saliva test kit to help anyone understand their circadian rhythm; it aims to reduce side effects from cancer treatments.

Mosqitter is turning its mosquito traps into an AI-powered surveillance network

Mosqitter is turning its mosquito-trapping hardware into an AI-powered surveillance network designed to identify species, monitor populations, and provide earlier warnings of mosquito-borne disease risks.

Save 50% on your TechCrunch Disrupt 2026 ticket and join the last 2 days in San Francisco’s Moscone West

Get 50% discount on the last two days of TechCrunch Disrupt 2026, Oct. 14-25, in San Francisco’s Moscone West. Register now and join the rest of the startup ecosystem. Today, it’s all about physical and software AI.

TechCrunch Disrupt 2026: Day 2

Day 2 at TechCrunch Disrupt 2026, full of all themes across AI, investor-only session, more roundtables, and more. Register to save 50% on your pass.

Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company’s work with PRIMA is part of its path toward a novel brain-computer interface (BCI).